Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: Meta‐analysis of randomized controlled trials

Elevated resting heart rate in chronic heart failure (HF) patients has been associated with higher mortality and poor prognosis. Ivabradine is a new pure bradycardic agent that has been used to treat angina or heart failure reduced ejection fraction (HFrEF) with sinus heart rate above 70 beats per m...

Descripción completa

Detalles Bibliográficos
Autores principales: Bryan Richard, Sasmita, Huang, Bi, Liu, Gang, Yang, Yuan, Luo, Suxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027585/
https://www.ncbi.nlm.nih.gov/pubmed/33638556
http://dx.doi.org/10.1002/clc.23581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027585/
https://www.ncbi.nlm.nih.gov/pubmed/33638556
http://dx.doi.org/10.1002/clc.23581

Ejemplares similares